Navigation Links
Take Heart If Your Parents Died at a Ripe Old Age: Framingham Heart Study

the basis has to do with risk factors. "You don't have to say, 'My parents died young so I can't do anything about it.' What this suggests to me is, 'Why don't you change the risk factors?' ", Benjamin opines.

In an editorial about the article, Dr. Clyde B. Schecter of Albert Einstein College of Medicine expresses his queries, "Heart disease accounts for a large enough proportion of all deaths that any factor that promotes exceptional longevity almost inevitably must lead to decreased risk of cardiac death."

The Framingham researchers are pursuing answers to these, in the genes.

A genome-wide scan of participants across the generations in the study began last autumn with genotyping that Levy expects to be completed by the end of summer.

"Longevity may be related to risk factors we don't yet know," he says.

"We intend to look at the genetic variations that may differentiate children whose parents live to an old age from children whose parents died at a young age."
AN
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart
Post Your Comments:
(Date:12/1/2008)...ARLOTTE, N.C., Dec. 1 I..., Emeka Okafor, will be launching a mobile textin...can Lives Initiative (OMALI), a program of the Saf... the Initiative is to save one million lives in Af... blood testing kits and clinical training. , ...
(Date:12/1/2008)...NTA MONICA, Calif., Dec. 1 TOMS Sh...ched a holiday campaign online at TOMSshoes.com,...s holiday season. For 30,days, from November 20th...oppers to help give 30,000 pairs of shoes to child...ease that is 100% preventable by wearing shoes. By...
(Date:12/1/2008)..., , , , Ideas from U-M physician inc..., Mich., Dec. 1 A bottl...e are all quick and easy gifts to buy and wrap for...ot give something more healthy and beneficial to a... , Staying healthy around the holidays can be ...
(Date:12/1/2008)... JOLLA, Calif., Dec. 1 TorreyPines...nced that oral administration of NGX426, an,AMPA/...trated a statistically,significant reduction in s...d,pain state) and allodynia (pain resulting from ...d to placebo following intradermal injections of c...
Breaking Medicine News(10 mins):Health News:In Recognition of WORLD AIDS DAY, Charlotte Bobcats' Power Forward, Emeka Okafor, Launches Mobile Texting Campaign in Support of the One Million African Lives Initiative 2Health News:TOMS Shoes Embarks on a Holiday Mission: Give 30,000 Pairs in 30 Days! 2Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 2Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 3Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 5
...als a new immune defense mechanism in normal airwa...ibrosis (CF) are particularly susceptible to bacte...the way to new approaches for treating the disease...enerate and use reactive oxygen species (ROS) to d...
...teroid, can prevent skin abnormalities induced by ...m the December //issue of the American Journal of ... Physiology. The new study also shows how psycholo...d initiate or worsen skin disorders such as psoria...
...g women who grow up in cities or move there from r...// Princess Diana was known to suffer from this e... in the country, and moved to London as a teenager...der in which young women get trapped in a routine ...
...e Family Restaurant at Lloydminister, has tested p...by a virus and affects the liver and causes fever,...iscomfort followed by yellow jaundice a few days l...ion of this virus from the worker to patrons of th...
Other Medicine News:Health News:Newly Discovered Immune Defense May Be Impaired In CF Airways 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 3
(Date:11/28/2008)...ll/ -- Eli Lilly and Company,(NYSE: LLY ) has w...DA) from,the U.S. Food and Drug Administration (F...gement of chronic pain. Lilly plans to resubmit th...ata from a recently completed positive study,in c...he decision does not affect duloxetine,s FDA-appro...
(Date:11/25/2008)... , Audio and Web Video Resources to accompan... Blog. Please see the bottom of this release for d... A Mayo Clinic study sho...re having a stroke -- and as a result -- delay see...findings appear in the current issue of Emergency ...
(Date:11/25/2008)...rstCall/ -- Pharmacyclics, Inc.,(Nasdaq: PCYC )...Phase 1,clinical trial with PCI-27483, the compan...IIa inhibitor. The trial was conducted in sixteen ...d pharmacologic effect of,PCI-27483. A single adm...,response in the International Normalized Ratio (...
(Date:11/24/2008)...stCall/ -- Leaders of Schering-Plough Corporation ...ors on the company,s research pipeline, highlighti...6 new entities in clinical trials or under regulat... "Research and development is adding strength an...ansformation," said Fred Hassan, chairman and CEO....
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Silent streams 3F Escalating endangerment for North American freshwater fish 4797 1Silent streams 3F Escalating endangerment for North American freshwater fish 4797 2Silent streams 3F Escalating endangerment for North American freshwater fish 4797 3Med School Diversity May Help Whites Care Better for Minorities 26203 1Med School Diversity May Help Whites Care Better for Minorities 26203 2Med School Diversity May Help Whites Care Better for Minorities 26203 3Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 1Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 2Young African American Males Face Mental Health Crisis 3B Experts Call For New Treatment Strategies and Better Access to Care 26199 3Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 1Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 2Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 3Medco CEO Unveils Pragmatic Blueprint for Health Care Reform 3B Reducing Costs by Upwards of 241 Trillion 26195 4
...ata being presented today at Digestive Disease Wee...- Microbia today,announced the presentation of dat...rated colonic transit and improved bowel function,...le bowel syndrome,(IBS-C). These data also showed ...e of adverse events. Linaclotide is a first-in-cla...
...HEIM, Calif.--(BUSINESS WIRE)--May 21, 2007 - Anti...nal follow-up data on the,company,s Phase 3 invest...(vitespen). The end-of-study results, which reflec... that in a substantial,subset of patients (n = 362...ophage demonstrated a clinically significant,impro...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6
CenterPointLock Drainable Mini-Pouch, White
CenterPointLock Cut-to-Fit SoftFlex Skin Barrier, Flat
CenterPointLock Closed Pouch, White
Inquire
Medicine Products: